Journal of Virology, September 2001, p. 7872-7874, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.7872-7874.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Copper Binding to the PrP Isoforms: a Putative
Marker of Their Conformation and Function
Yuval
Shaked,
Hana
Rosenmann,
Nuha
Hijazi,
Michele
Halimi, and
Ruth
Gabizon*
Department of Neurology, The Agnes Ginges
Center for Human Neurogenetics, Hadassah University Hospital,
Jerusalem, Israel
Received 25 January 2001/Accepted 18 May 2001
 |
ABSTRACT |
We show here that PrPC, the normal isoform of the prion
protein (PrPSc), could be retained by a
Cu2+-loaded resin through two different binding sites.
Contrarily, PrPSc was not retained at all by such resin.
This constitutes a new prion-specific property of PrPSc,
which in addition to protease resistance and
-sheet content, may
result from its aberrant conformation.
 |
INTRODUCTION |
PrPC is the normal
isoform of PrPSc, the protein component of the prion.
Prions cause transmissible neurodegenerative diseases such as scrapie
and bovine spongiform encephalopathy as well as Creutzfeldt-Jakob
disease in humans (12). The two PrP isoforms have the same
amino acid sequence, but in contrast to PrPC,
PrPSc comprises a protease-resistant core peptide
denominated PrP27-30. The function of PrPC is still
unknown, despite the creation and investigation of several lines of
PrP0/0 mice (2). The only clue for the
function of PrPC is the finding that it binds copper
specifically (14, 16).
The established copper binding site on PrP was shown to be comprised in
its N-terminal eight tandem repeats (octarepeats) (3).
However, Pan et al. (11) showed that when PrPC
was purified on a Cu2+-loaded immobilized metal affinity
chromatography (IMAC) resin, an N-terminally truncated metabolite of
PrPC (called PrPII) was also enriched. This suggests the
presence of a second copper binding site on PrP, downstream from the
N-terminal repeats. This conclusion, however, should be considered with
caution, since in the case of a Cu2+-loaded IMAC resin, the
Cu2+ ions are ligated to both the immobilized chelator on
the resin and the protein simultaneously, not to the protein only.
In this work, we examined the elution profiles of the PrP isoforms
(PrPC and PrPSc) as well as of their
metabolites from a Cu2+-loaded IMAC resin at increasing
imidazole concentrations. Our results show that as opposed to
PrPC and denatured PrPSc, both native
PrPSc and PrP27-30 were not retained by the
Cu2+-loaded resin. This constitutes a new prion-specific
property of PrPSc, which in addition to protease resistance
and
-sheet content, probably results from its aberrant conformation.
 |
MATERIALS AND METHODS |
Fifty-microgram aliquots of brain or cells membranes were
extracted with 2.5 ml of cold 1% Triton X-100 in phosphate-buffered saline (Triton-PBS) and subsequently mixed for 1 h at room
temperature with an IMAC resin which was previously loaded with copper
ions as described elsewhere (11). The resin was
precipitated by centrifugation, and the nonbound extract was designated
the flowthrough. The IMAC resin was washed four times with 2.5 ml of
Triton-PBS. The attached proteins were eluted from the resin by the
addition of 2.5 ml of imidazole at increasing concentrations (0.05 M
twice, 0.1 M twice, and 0.2 M twice). Finally, 2.5 ml of 50 mM EDTA was
used (twice) to release the copper ions from the IMAC resin. Other scrapie extracts were denatured with 3 M (final concentration) guanidium isothiocyanate (GuSCN) for 30 min and precipitated with 4 volumes of methanol before resuspension in Triton-PBS and application to the resin. All eluted fractions were recovered by centrifugation of
the resin and subsequently immunoblotted with the appropriate antibodies.
 |
RESULTS AND DISCUSSION |
A 2% Triton X-100 extract of normal hamster brain membranes was
incubated with a Cu2+-loaded IMAC resin and subsequently
eluted as described in Materials and Methods. When the eluted fractions
were immunoblotted with anti-PrP monoclonal antibody (MAb)3F4 (Fig.
1a), which reacts with residues 108 to
111 in hamster or human PrP (5), only full-length PrP was
detected, mostly in the fractions eluted with high imidazole
concentrations or EDTA. When the same fractions were immunoblotted with
MAb 6H4 (Prionics, Zurich, Switzerland), which reacts with PrP residues
144 to 152 (Fig. 1b), a shorter PrP peptide was also detected, but at
the fractions eluted with low imidazole concentrations. These results
suggest that this shorter PrP, which did not react with MAb 3F4 and
thereby must be truncated at its N terminus, still binds to a
Cu2+-loaded IMAC resin, albeit with a lower affinity than
full-length PrP. Since, like the PrPII described by Pan et al.
(11), it lacks the putative PrP copper binding site
present in the N-terminal octarepeats (IMAC1), it must comprise another
Cu2+ IMAC retention site (IMAC2).

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 1.
Two copper binding sites on PrPC. (a to c)
Triton X-100 extracts from normal hamster brains were applied to and
eluted from a Cu2+-loaded IMAC resin as described in
Materials and Methods. (a) Flowthrough samples, washes, and eluted
samples immunoblotted with anti-PrP MAb 3F4; (b) same samples
immunoblotted with MAb 6H4; (c) Triton X-100 extract incubated with the
anti-P5 antiserum applied to the resin, eluted as above, and
immunoblotted with MAb 6H4; (d) Triton X-100 extracts from mature sperm
cells were applied to a Cu2+-loaded IMAC resin. Flowthrough
samples, washes, and eluted samples were immunoblotted with anti-PrP
MAb 6H4.
|
|
Both PrP isoforms are associated with cholesterol-rich membrane
microdomains called rafts (9, 15). To establish whether PrPC binds directly to the Cu2+-loaded resin or
is attached to it through a neighbor raft protein, the normal Triton
X-100 extract was incubated with the anti-PrP antiserum (reacting
against residues 142 to 172) (1) before being applied to
the IMAC resin. In the presence of this antiserum (Fig. 1c), the
N-terminally truncated PrP was eluted mostly in the flowthrough, while
full-length PrP was eluted at considerable lower imidazole
concentrations, suggesting that the anti-PrP antiserum lowered the
affinity of PrP peptides to the Cu2+-loaded IMAC resin.
These results indicate that PrPC binds to the copper-loaded
resin directly, but although suggestive, they do not prove that the
IMAC2 retention site lies between residues 142 and 174, since the
antibody may also hinder the binding of copper to a nearby site of the
protein. As expected from previous results (11), an IMAC
resin loaded with zinc did not show any specific PrP retention (not shown).
We have shown recently that in mature sperm cells, PrP is truncated at
its C terminus, probably between the two PrP N-glycosylation sites
(residues 181 and 197) (13). Human ejaculates containing mature sperm cells were extracted in Triton X-100, applied to a
Cu2+-loaded IMAC resin, and eluted as described above for
brain extracts. All sperm PrP, which comprises the N-terminal but not
the C-terminal part of PrP, was retained by the copper resin and eluted
at low imidazole concentrations (Fig. 1d). These results indicate that the additional Cu2+ retention site may reside in the
C-terminal part of PrP.
To determine whether PrPSc and PrP27-30 can be retained by
a Cu2+-loaded IMAC resin, membranes from scrapie-infected
hamster brains were extracted with Triton X-100 and applied to an IMAC
resin as described for normal brain membranes. PrPSc
molecules aggregate in the presence of detergents such as Sarkosyl (7), but this is not the case for scrapie-infected
membranes extracted in cold Triton X-100, in which PrPSc is
still incorporated into rafts and therefore does not aggregate (8).
Compared to normal brain membranes (Fig.
2a), most of the total PrP present in the
extract (PrPC and PrPSc) was found in the
flowthrough and not in any of the retained fractions (Fig. 2b).
Moreover, all PrP was detected in the flowthrough when the samples were
digested with proteinase K (PK) before immunoblotting (Fig. 2c) or when
the Triton X-100 scrapie-infected extract was digested with PK before
application to the Cu2+-loaded IMAC resin (Fig. 2d). These
results suggest that both PrPSc and PrP27-30 did not bind
to a Cu2+-loaded IMAC resin. When the scrapie membranes
were first denatured by 3 M GuSCN, the PrP protein was retained by the
resin at the same fashion as PrPC, suggesting the
difference in retention of PrPC and PrPSc by a
Cu2+-loaded IMAC resin results from the aberrant
conformation of PrPSc (Fig. 2e). Similar results were
obtained previously for sodium dodecyl sulfate-denatured
PrPSc (4). The fact that only a small fraction
of total PrP molecules were retained by the Cu2+-loaded
IMAC resin before PK digestion suggests that the concentration of
functional PrPC is very low in extracts from
scrapie-infected brains. These results are consistent with those
presented in a recent publication suggesting that specific
anti-PrPC antibodies react very poorly with
scrapie-infected brain samples (17).

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 2.
PrPSc and PrP27-30 do not bind copper.
Triton X-100 extracts from normal and scrapie-infected hamster brains
were applied to and eluted from a Cu2+-loaded IMAC resin as
described in Materials and Methods and the legend to Fig. 1. Before
immunoblotting, the eluted scrapie brain samples were digested in the
presence and absence of PK (50 µg/ml). Part of the scrapie extracts
were digested with PK before the application to the resin. (a) Normal
hamster brain; (b) scrapie-infected hamster brain; (c) scrapie samples
digested with PK before immunoblotting; (d) scrapie samples digested
with PK before application to the Cu2+-loaded IMAC resin;
(e) scrapie samples after denaturation with 3 M GuSCN. Panels a and b
were immunoblotted with MAb 3F4; panels c to e were immunoblotted with
MAb 6H4.
|
|
The fact that PrPSc, as opposed to PrPC, does
not bind to a Cu2+-loaded IMAC resin constitutes a newly
identified difference between the two prion protein isoforms, which
until now were distinguished mostly by their protease resistance and
-sheet content (6, 10). That full-length
PrPSc is not retained by a Cu2+-loaded IMAC
resin may be specifically important, since it suggests that also the
N-terminal part of PrPSc, which is not protease resistant
and does not present a
-sheet structure, may differ in conformation
from the N-terminal part of PrPC. It will be interesting to
test the Cu2+-loaded IMAC resin retention properties of
pathogenic mutant PrPs before they acquire protease resistance to
determine whether they resemble PrPC or PrPSc.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Neurology, Hadassah University Hospital, Jerusalem, Israel 91120. Phone: 972-2-6777858. Fax: 972-2-6429441. E-mail:
gabizonr{at}hadassah.org.il.
 |
REFERENCES |
| 1.
|
Barry, R. A.,
M. T. Vincent,
S. B. Kent,
L. E. Hood, and S. B. Prusiner.
1988.
Characterization of prion proteins with monospecific antisera to synthetic peptides.
J. Immunol.
140:1188-1193[Abstract].
|
| 2.
|
Bueler, H.,
M. Fischer,
Y. Lang,
H. Bluethmann,
H. P. Lipp,
S. J. DeArmond,
S. B. Prusiner,
M. Aguet, and C. Weissmann.
1992.
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.
Nature
356:577-582[CrossRef][Medline].
|
| 3.
|
Hornshaw, M. P.,
J. R. McDermott, and J. M. Candy.
1995.
Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein.
Biochem. Biophys. Res. Commun.
207:621-629[CrossRef][Medline].
|
| 4.
|
Ishikawa, Y.,
S. Ito,
S. Nishino,
S. Ohba, and Y. Nishida.
1998.
Contribution of a peroxide adduct of copper(II)-peptide complex to modify the secondary structure of albumin.
Z. Naturforsch. C
53:378-382.
|
| 5.
|
Kascsak, R. J.,
R. Rubenstein,
P. A. Merz,
M. Tonna DeMasi,
R. Fersko,
R. I. Carp,
H. M. Wisniewski, and H. Diringer.
1987.
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.
J. Virol.
61:3688-3693[Abstract/Free Full Text].
|
| 6.
|
McKinley, M. P.,
D. C. Bolton, and S. B. Prusiner.
1983.
A protease-resistant protein is a structural component of the scrapie prion.
Cell
35:57-62[CrossRef][Medline].
|
| 7.
|
McKinley, M. P.,
R. K. Meyer,
L. Kenaga,
F. Rahbar,
R. Cotter,
A. Serban, and S. B. Prusiner.
1991.
Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.
J. Virol.
65:1340-1351[Abstract/Free Full Text].
|
| 8.
|
Naslavsky, N.,
R. Stein,
A. Yanai,
G. Friedlander, and A. Taraboulos.
1997.
Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.
J. Biol. Chem.
272:6324-6331[Abstract/Free Full Text].
|
| 9.
|
Naslavsky, N.,
R. Stein,
A. Yanai,
G. Friedlander,
S. B. Prusiner, and A. Taraboulus.
1997.
Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.
J. Biol. Chem.
272:6324-6331.
|
| 10.
|
Pan, K. M.,
M. Baldwin,
J. Nguyen,
M. Gasset,
A. Serban,
D. Groth,
I. Mehlhorn,
Z. Huang,
R. J. Fletterick,
F. E. Cohen, et al.
1993.
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.
Proc. Natl. Acad. Sci. USA
90:10962-10966[Abstract/Free Full Text].
|
| 11.
|
Pan, K. M.,
N. Stahl, and S. B. Prusiner.
1992.
Purification and properties of the cellular prion protein from Syrian hamster brain.
Protein Sci.
1:1343-1352[Abstract].
|
| 12.
|
Prusiner, S. B.
1998.
Prions.
Proc. Natl. Acad. Sci. USA
95:13363-13383[Abstract/Free Full Text].
|
| 13.
|
Shaked, Y.,
H. Rosenmann,
G. Talmor, and R. Gabizon.
1999.
A C-terminal-truncated PrP isoform is present in mature sperm.
J. Biol. Chem.
274:32153-32158[Abstract/Free Full Text].
|
| 14.
|
Stockel, J.,
J. Safar,
A. C. Wallace,
F. E. Cohen, and S. B. Prusiner.
1998.
Prion protein selectively binds copper(II) ions.
Biochemistry
37:7185-7193[CrossRef][Medline].
|
| 15.
|
Taraboulos, A.,
M. Scott,
A. Semenov,
D. Avrahami,
L. Laszlo,
S. B. Prusiner, and D. Avraham.
1995.
Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.
J. Cell Biol.
129:121-132[Abstract/Free Full Text].
|
| 16.
|
Viles, J. H.,
F. E. Cohen,
S. B. Prusiner,
D. B. Goodin,
P. E. Wright, and H. J. Dyson.
1999.
Copper binding to the prion protein: structural implications of four identical cooperative binding sites.
Proc. Natl. Acad. Sci. USA
96:2042-2047[Abstract/Free Full Text].
|
| 17.
|
Yokoyama, T.,
K. M. Kimura,
Y. Ushiki,
S. Yamada,
A. Morooka,
T. Nakashiba,
T. Sassa, and S. Itohara.
2001.
In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies.
J. Biol Chem.
276:11265-11271[Abstract/Free Full Text].
|
Journal of Virology, September 2001, p. 7872-7874, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.7872-7874.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.